Advisory Committee on Breast Cancer in Young Women; Meeting, 18318 [2023-06316]
Download as PDF
<![CDATA[
18318
Federal Register / Vol. 88, No. 59 / Tuesday, March 28, 2023 / Notices
areas; and persons otherwise adversely
affected by persistent poverty or
inequality. Nominations of persons with
expertise in health care for these
priority populations are encouraged.
Dated: March 21, 2023.
Marquita Cullom,
Associate Director.
[FR Doc. 2023–06332 Filed 3–27–23; 8:45 am]
BILLING CODE 4160–90–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Advisory Committee on Breast Cancer
in Young Women; Meeting
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice of meeting.
AGENCY:
In accordance with regulatory
provisions, the Centers for Disease
Control and Prevention (CDC)
announces the following meeting for the
Advisory Committee on Breast Cancer
in Young Women (ACBCYW). This
meeting is open to the public, limited
only by audio and web conference lines
(150 web conference participant spaces
available). Online registration is
required.
DATES: The meeting will be held on May
10, 2023, 11 a.m. to 4:30 p.m., EDT.
ADDRESSES: This meeting is virtual.
Online Registration Required: All
ACBCYW Meeting participants must
register for the meeting online at least 2
business days in advance at https://
www.cdc.gov/cancer/breast/what_cdc_
is_doing/conference.htm. Please
complete all the required fields and
submit your registration no later than
May 8, 2023. Registered participants
will receive the audio and web
conference access instructions before
the meeting.
FOR FURTHER INFORMATION CONTACT:
Kimberly E. Smith, MBA, MHA,
Designated Federal Officer, National
Center for Chronic Disease Prevention
and Health Promotion, Centers for
Disease Control and Prevention, 4770
Buford Hwy. NE, Mailstop S107–4,
Atlanta, Georgia 30341, Telephone (404)
498–0073, Fax (770) 488–4760. Email:
acbcyw@cdc.gov.
SUPPLEMENTARY INFORMATION:
Purpose: The Committee provides
advice and guidance to the Secretary,
HHS; the Assistant Secretary for Health;
and the Director, CDC, regarding the
formative research, development,
lotter on DSK11XQN23PROD with NOTICES1
SUMMARY:
VerDate Sep<11>2014
16:59 Mar 27, 2023
Jkt 259001
implementation and evaluation of
evidence-based activities designed to
prevent breast cancer (particularly
among those at heightened risk) and
promote the early detection and support
of young women who develop the
disease. The advice provided by the
Committee will assist in ensuring
scientific quality, timeliness, utility, and
dissemination of credible appropriate
messages and resource materials.
Matters to be Considered: The agenda
will include discussions on current
topics related to breast cancer in young
women. These will include Mental/
Behavioral Health, Sexual Health,
Genetics and Genomics, and Provider
Engagement. Agenda items are subject
to change as priorities dictate.
The Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit,
Office of the Chief Operating Officer, Centers
for Disease Control and Prevention.
[FR Doc. 2023–06316 Filed 3–27–23; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
Statement of Organization, Functions,
and Delegations of Authority
Centers for Medicare &
Medicaid Services, HHS.
SUMMARY: The Centers for Medicare and
Medicaid Services, Center for Medicare,
Office of Minority Health has modified
its organizational structure.
SUPPLEMENTARY INFORMATION: Part F of
the Statement of Organization,
Functions, and Delegations of Authority
for the Department of Health and
Human Services, Centers for Medicare &
Medicaid Services (CMS) (last amended
at Federal Register, Vol. 87, No. 205,
pp. 64492–64494, dated October 25,
2022) is amended to reflect the
establishment of the Business
Operations Services & Engagement
Group within the CMS Office of
Minority Health (OMH).
Part F, Section FC. 10 (Organization)
is revised as follows:
AGENCY:
PO 00000
Frm 00027
Fmt 4703
Sfmt 4703
Office of Minority Health, Business
Operations Services and Engagement
Group Part F, Section FC. 20 (Functions)
for the new organization is as follows:
Business Operations Services &
Engagement Group
• Serves as the focal point on all CMS
Office of Minority Health (OMH) shared
business operations that affect the
management of CMS OMH. This
includes matters related to budget,
human capital, facilities, technology,
and internal communications.
• Manages and coordinates the
correspondence program for CMS OMH,
acquisition planning, human capital
management, staff development, awards
and recognition, and management of
travel, space, computers, telephones,
and other business resources.
• Develops policies and provides
policy direction, coordination, and
support for CMS OMH business services
including budget formulation and
execution, procurement planning,
information technology management,
facilities support, correspondence
management, and human resources
management.
• Monitors CMS OMH business
operations, identifies Office/Group
information needs and requirements,
and coordinates necessary
implementation activities with the
Office of Financial Management (OFM),
Office of Acquisition and Grants
Management, Office of Information
Technology, and the Chief Operating
Officer.
• Formulates, executes, and manages
the budget, procurement, operating plan
for CMS OMH programs. Prepares
briefing materials to defend budget to
the Department, Office of Management
and Budget (OMB), and Congress.
• Represents CMS OMH in meetings
with CMS, the Department of Health
and Human Services (HHS), and OMB
officials regarding financing these
initiatives.
• Collaborate with the Office of
Acquisition and Grants Management to
develop and negotiate large-scale
crosscutting contracts and inter/intra
agency agreements, which include the
development of contractor
specifications, work statements, and
evaluation criteria to support the Office
of the Secretary beneficiary service
functions and OMH business
operations.
• Represents CMS OMH leadership in
meetings with OFM involving CMS
OMH budget requirements. Provides
support for negotiating and finalizing
CMS formulation and execution plans,
analysis and development of additional
funding requests; analyses and
E:\FR\FM\28MRN1.SGM
28MRN1
]]>Agencies
[Federal Register Volume 88, Number 59 (Tuesday, March 28, 2023)]
[Notices]
[Page 18318]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-06316]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Advisory Committee on Breast Cancer in Young Women; Meeting
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice of meeting.
-----------------------------------------------------------------------
SUMMARY: In accordance with regulatory provisions, the Centers for
Disease Control and Prevention (CDC) announces the following meeting
for the Advisory Committee on Breast Cancer in Young Women (ACBCYW).
This meeting is open to the public, limited only by audio and web
conference lines (150 web conference participant spaces available).
Online registration is required.
DATES: The meeting will be held on May 10, 2023, 11 a.m. to 4:30 p.m.,
EDT.
ADDRESSES: This meeting is virtual. Online Registration Required: All
ACBCYW Meeting participants must register for the meeting online at
least 2 business days in advance at https://www.cdc.gov/cancer/breast/what_cdc_is_doing/conference.htm. Please complete all the required
fields and submit your registration no later than May 8, 2023.
Registered participants will receive the audio and web conference
access instructions before the meeting.
FOR FURTHER INFORMATION CONTACT: Kimberly E. Smith, MBA, MHA,
Designated Federal Officer, National Center for Chronic Disease
Prevention and Health Promotion, Centers for Disease Control and
Prevention, 4770 Buford Hwy. NE, Mailstop S107-4, Atlanta, Georgia
30341, Telephone (404) 498-0073, Fax (770) 488-4760. Email:
[email protected].
SUPPLEMENTARY INFORMATION:
Purpose: The Committee provides advice and guidance to the
Secretary, HHS; the Assistant Secretary for Health; and the Director,
CDC, regarding the formative research, development, implementation and
evaluation of evidence-based activities designed to prevent breast
cancer (particularly among those at heightened risk) and promote the
early detection and support of young women who develop the disease. The
advice provided by the Committee will assist in ensuring scientific
quality, timeliness, utility, and dissemination of credible appropriate
messages and resource materials.
Matters to be Considered: The agenda will include discussions on
current topics related to breast cancer in young women. These will
include Mental/Behavioral Health, Sexual Health, Genetics and Genomics,
and Provider Engagement. Agenda items are subject to change as
priorities dictate.
The Director, Strategic Business Initiatives Unit, Office of the
Chief Operating Officer, Centers for Disease Control and Prevention,
has been delegated the authority to sign Federal Register notices
pertaining to announcements of meetings and other committee management
activities, for both the Centers for Disease Control and Prevention and
the Agency for Toxic Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2023-06316 Filed 3-27-23; 8:45 am]
BILLING CODE 4163-18-P
